Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Study
NACompletedINTERVENTIONAL
Enrollment
36
Participants
Timeline
Start Date
January 1, 2021
Primary Completion Date
July 7, 2023
Study Completion Date
July 7, 2023
Conditions
SchizophreniaCannabis Use
Interventions
DRUG
Cannabidiol
CBD
DRUG
Placebo
Placebo
DRUG
Delta-9-THC
THC
Trial Locations (1)
SE58AZ
South London and Maudsley NHS Foundation Trust, London
All Listed Sponsors
lead
King's College London
OTHER
NCT04605393 - Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Study | Biotech Hunter | Biotech Hunter